Skip to main content

Table 4 Mean signal intensities of various proteins and peptides comparing endometrium of women with a normal pelvis versus stage III-IV endometriosis (CM10 and IMAC)

From: TRIzol treatment of secretory phase endometrium allows combined proteomic and mRNA microarray analysis of the same sample in women with and without endometriosis

CM10     
CHCA     
M/z pvalue Mean Disease Mean Control Up/down
9774,53 0,014 0,596 1,098 down
14653,82 0,008 0,445 1,468 down
SPAhigh     
14479,03 0,014 0,266 0,116 up
31793,90 0,036 1,596 0,142 up
SPAlow     
8172,88 0,014 0,237 0,417 down
8388,16 0,036 0,126 0,362 down
9177,29 0,022 0,145 1,381 down
9399,55 0,036 0,180 0,415 down
9616,30 0,008 0,100 0,307 down
11477,23 0,014 0,058 0,167 down
12623,72 0,036 0,340 0,219 up
12787,28 0,036 0,036 0,132 down
15765,886 0,036 2,103 0,186 up
IMAC     
CHCA     
M/z pvalue Mean Disease Mean Control Up/down
6299,9273 0,008113117 0,23461589 0,47046801 down
9213,5098 0,01371083 0,362215739 1,57790751 down
9266,2242 0,022478873 0,695244394 1,44011883 down
9766,1943 0,035763767 0,764862056 0,35977499 up
15446,04 0,008 0,985 0,108 up
SPAhigh     
9532,42 0,023 1,056 13,993 down
9767,55 0,036 1,436 4,258 down
13134,421 0,0137 0,23780214 0,53548423 down
SPAlow     
7716,86 0,036 0,587 0,253 up
7832,06 0,036 0,204 0,369 down
8228,62 0,022 0,291 0,198 up
9190,0544 0,00811312 0,21041195 1,4064187 down